Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 41,061 $ 52,886
Restricted cash, current 1,703 1,297
Contract receivables and retainage, net 23,643 15,986
Contract assets 2,694 4,759
Prepaid expenses and other assets 9,120 6,971
Inventory 1,700 1,779
Assets held for sale 1,800 1,800
Total current assets 81,721 85,478
Restricted cash, noncurrent   406
Property, plant and equipment, net 32,057 32,866
Goodwill 2,217 2,217
Other intangibles, net 949 984
Other noncurrent assets 13,261 13,322
Total assets 130,205 135,273
Current liabilities:    
Accounts payable 9,531 9,280
Contract liabilities 4,198 6,648
Accrued expenses and other liabilities 15,831 14,026
Total current liabilities 29,560 29,954
Other noncurrent liabilities 1,252 1,411
Total liabilities 30,812 31,365
Shareholders’ equity:    
Preferred stock, no par value, 5,000 shares authorized, no shares issued and outstanding
Common stock, no par value, 30,000 shares authorized, 15,775 shares issued and outstanding at March 31, 2022 and 15,622 at December 31, 2021 11,435 11,384
Additional paid-in capital 105,972 105,511
Accumulated deficit (18,014) (12,987)
Total shareholders’ equity 99,393 103,908
Total liabilities and shareholders’ equity $ 130,205 $ 135,273